Edex and Fibroadenoma - breast - a phase IV clinical study of FDA data
We study 462 people who take Edex or have Fibroadenoma - breast. No report of Fibroadenoma - breast is found in people who take Edex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Edex?
Edex has active ingredients of alprostadil. eHealthMe is studying from 460 Edex users for its effectiveness, alternative drugs and more.
What is Fibroadenoma - Breast?
Fibroadenoma - breast: no further information found.
Do you take Edex and have Fibroadenoma - breast?Check whether Fibroadenoma - breast is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Fibroadenoma - breast and when was it recovered:
Expand to all the drugs that have ingredients of alprostadil:
Alternative drugs to, pros and cons of Edex:
- Edex (460 reports)
Fibroadenoma - breast treatments and more:
- Fibroadenoma - breast (2 reports)
COVID vaccines that are related to Fibroadenoma - breast:
- Fibroadenoma - breast in Moderna COVID Vaccine
- Fibroadenoma - breast in Pfizer BioNTech Covid Vaccine
- Fibroadenoma - breast in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Fibroadenoma - breast:
All the conditions that are associated with Fibroadenoma - breast:
How the study uses the data?
The study uses data from the FDA. It is based on alprostadil (the active ingredients of Edex) and Edex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Abilify and Overdose - 27 seconds ago
- Actemra and Gabapentin drug interaction - 55 seconds ago
- Type 2 Diabetes and Distributive Shock - a minute ago
- Estratab and Gastroesophageal Reflux Disease - a minute ago
- Prilosec and Ureteric Obstruction - a minute ago
- Cartia Xt and Viral Pericarditis - a minute ago
- Vioxx and Essential Tremor - a minute ago
- Paroxetine Hydrochloride and Throat Tightness - a minute ago
- Namenda and Eye Haemorrhage - 2 minutes ago
- Cardura and Omacor drug interaction - 2 minutes ago